EU and US could reach trade deal this weekend - Reuters
NORTHBROOK, Ill. - IDEX Corporation (NYSE:IEX), a global provider of engineered products and components with a market capitalization of $14.1 billion, has announced the approval of a regular quarterly cash dividend by its Board of Directors. The dividend of $0.71 per common share, representing a yield of 1.53%, is slated for distribution on May 30, 2025, to shareholders on record as of May 19, 2025. According to InvestingPro data, the company has consistently raised its dividend for 15 consecutive years.
This forthcoming dividend marks the 122nd consecutive regular quarterly cash dividend payment by IDEX, reflecting its commitment to providing consistent returns to its investors. The company has maintained dividend payments for 31 consecutive years, showcasing its financial stability and dedication to sharing profits with its shareholders. InvestingPro analysis reveals the company operates with a moderate debt level and maintains strong liquidity, with current assets exceeding short-term obligations by nearly 2.8 times.
IDEX Corporation has a diversified business model, with more than 50 businesses under its umbrella and operations spanning over 20 countries. With approximately 9,000 employees worldwide, the company reported annual sales of $3.28 billion and maintains a healthy gross profit margin of 44.6%. Its product portfolio includes mission-critical components that serve various industries, from electronics and water treatment to healthcare and fire rescue. Based on InvestingPro’s Fair Value analysis, the stock is currently trading near its fair value, with 8 additional ProTips available for subscribers.
The company’s engineered products play a vital role in everyday life, contributing to the manufacturing of microchips, the treatment of drinking water, and the provision of broadband satellite communications, among other applications. IDEX components are also integral to life-saving healthcare equipment, such as DNA sequencers used in personalized medical treatments. The company maintains a P/E ratio of 29.4, reflecting investor confidence in its growth potential. Discover comprehensive insights and detailed financial analysis in IDEX’s Pro Research Report, available exclusively on InvestingPro.
IDEX’s commitment to innovation and quality is evident in its broad range of products, including the Hurst Jaws of Life®, which is recognized as an industry leader and trusted by rescue workers globally.
The announcement of the dividend payment is based on a press release statement from IDEX Corporation. Investors and those interested in the company’s financial practices may view this regular dividend as a sign of IDEX’s ongoing performance and its ability to generate shareholder value over time.
In other recent news, IDEX Corporation reported impressive first-quarter 2025 earnings, exceeding analyst expectations with an earnings per share (EPS) of $1.75, compared to the forecasted $1.67. The company also surpassed revenue projections, reporting $872 million against the anticipated $810.42 million. These results reflect IDEX’s strategic focus on innovation and cost optimization, despite a slight decrease in organic sales and adjusted EBITDA margin. Additionally, Stifel has raised its price target for IDEX shares from $192 to $208, maintaining a Buy rating. The analysts highlighted IDEX’s solid order growth and proactive cost reductions as factors enhancing confidence in the company’s short-term outlook. They also praised IDEX’s platform strategy, which is expected to accelerate growth and improve profit margins. These developments indicate a positive trajectory for IDEX amidst potential economic challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.